Zoetis Share Price (NYSE: ZTS)

$155.4

▲

0.21

(0.14%)

Live

Last updated on August 27, 2025 at 1:29 AM IST

$₹

Check the interactive Zoetis Stock chart to analyse performance

Zoetis stock performance

as on August 27, 2025 at 1:29 AM IST

Today's Low:$155.10
Today's High:$156.07
$155.40
0.19%
Downside
Day's Volatility :0.62%
Upside
0.43%
52 Weeks Low:$139.70
52 Weeks High:$200.33
$155.40
10.1%
Downside
52 Weeks Volatility :30.27%
Upside
22.43%

Zoetis Stock Returns

Period	Zoetis Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.69%	4.5%	0.0%
6 Months	-7.95%	-7.9%	0.0%
1 Year	-14.56%	-12.3%	0.0%
3 Years	-1.74%	7.0%	-6.9%

Zoetis Inc. Key Stats

Check Zoetis key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$155.19
Open	$155.59
Today's High	$156.07
Today's Low	$154.69
Market Capitalization	$68.8B
Today's Volume	$1.8M
52 Week High	$200.33
52 Week Low	$139.7
Revenue TTM	$9.4B
EBITDA	$3.9B
Earnings Per Share (EPS)	$5.81
PE Ratio	26.71
Dividend Yield	1.19%
Profit Margin	27.83%
Quarterly Earnings Growth YOY	0.18%
Return On Equity TTM	52.77%

Stock Returns calculator for Zoetis Stock including INR - Dollar returns

The Zoetis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zoetis investment value today

Current value as on today

₹90,119

Returns

₹9,881

(-9.88%)

Returns from Zoetis Stock

₹14,408 (-14.41%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Zoetis Stock

-6.78%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Investment in Zoetis Shares from India has dropped by -6.78% over the past 30 days, indicating reduced transactional activity.

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Zoetis Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Zoetis Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	3599	-21.20	0.12%

Global Institutional Holdings in Zoetis Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
9.44%
BlackRock Inc
8.67%
State Street Corp
4.46%
State Farm Mutual Automobile Ins Co
3.58%
Morgan Stanley - Brokerage Accounts
2.87%
Geode Capital Management, LLC
2.47%

Analyst Recommendation on Zoetis Stock

Rating

Trend

Buy

86%Buy

13%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Zoetis(by analysts ranked 0 to 5 stars)

Zoetis Share Price Target

What analysts predicted

Upside of 22.45%

Target:

$190.29

Current:

$155.40

Zoetis share price target is $190.29, a slight Upside of 22.45% compared to current price of $155.40 as per analysts' prediction.

Zoetis Stock Insights

Price Movement
In the last 7 days, ZTS stock has moved down by -0.3%
Increasing Revenue
Zoetis Inc. has shown positive revenue growth over the last two quarters, increasing from $2.22 billion to $2.46 billion. This represents an average quarterly increase of 9.8%.
Increasing Net Profit
Zoetis Inc. has shown positive profit growth over the last three quarters. The net profit increased from $581.0 million to $718.0 million, with an average growth rate of 10.0% per quarter.
ZTS vs HLN (1 yr)
In the last 1 year, Zoetis Inc. has experienced a drawdown of -14.6%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 12.6%
ZTS vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 55.2% return, outperforming this stock by 58.2%
Price to Sales
Zoetis Inc. has a Price-to-Sales Ratio (P/S Ratio) of 7.4, meaning that investors are willing to pay $7.4 for every $1 of sales generated by the company. In comparison, Haleon Plc Spon Ads has a P/S Ratio of 4.0, indicating that investors pay $4.0 for every $1 of sales. This suggests that investors value Zoetis Inc. more highly relative to its sales than they do Haleon Plc.

Zoetis Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$6.3B	↑ 7.47%
Net Income	$1.5B	↑ 5.04%
Net Profit Margin	23.96%	↓ 0.56%

	FY20	Y/Y Change
Revenue	$6.7B	↑ 6.63%
Net Income	$1.6B	↑ 9.2%
Net Profit Margin	24.54%	↑ 0.58%

	FY21	Y/Y Change
Revenue	$7.8B	↑ 16.49%
Net Income	$2.0B	↑ 24.36%
Net Profit Margin	26.2%	↑ 1.66%

	FY22	Y/Y Change
Revenue	$8.1B	↑ 3.91%
Net Income	$2.1B	↑ 3.78%
Net Profit Margin	26.16%	↓ 0.04%

	FY23	Y/Y Change
Revenue	$8.5B	↑ 5.74%
Net Income	$2.3B	↑ 10.88%
Net Profit Margin	27.43%	↑ 1.27%

	FY24	Y/Y Change
Revenue	$9.3B	↑ 8.33%
Net Income	$2.5B	↑ 6.06%
Net Profit Margin	26.86%	↓ 0.57%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.2B	↓ 1.04%
Net Income	$599.0M	↑ 14.1%
Net Profit Margin	27.35%	↑ 3.63%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 7.81%
Net Income	$624.0M	↑ 4.17%
Net Profit Margin	26.43%	↓ 0.92%

	Q3 FY24	Q/Q Change
Revenue	$2.4B	↑ 1.14%
Net Income	$682.0M	↑ 9.29%
Net Profit Margin	28.56%	↑ 2.13%

	Q4 FY24	Q/Q Change
Revenue	$2.3B	↓ 2.97%
Net Income	$581.0M	↓ 14.81%
Net Profit Margin	25.08%	↓ 3.48%

	Q1 FY25	Q/Q Change
Revenue	$2.2B	↓ 4.19%
Net Income	$631.0M	↑ 8.61%
Net Profit Margin	28.42%	↑ 3.34%

	Q2 FY25	Q/Q Change
Revenue	$2.5B	↑ 10.81%
Net Income	$718.0M	↑ 13.79%
Net Profit Margin	29.19%	↑ 0.77%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$4.1B	↑ 8.32%

	FY20	Y/Y Change
Profit	$4.5B	↑ 8.39%

	FY21	Y/Y Change
Profit	$5.3B	↑ 19.16%

	FY22	Y/Y Change
Profit	$5.5B	↑ 3.09%

	FY23	Y/Y Change
Profit	$5.8B	↑ 6.54%

	FY24	Y/Y Change
Profit	$6.4B	↑ 9.63%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.5B	↑ 4.28%

	Q2 FY24	Q/Q Change
Profit	$1.7B	↑ 9.8%

	Q3 FY24	Q/Q Change
Profit	$1.7B	↓ 0.36%

	Q4 FY24	Q/Q Change
Profit	$1.6B	↓ 4.6%

	Q1 FY25	Q/Q Change
Profit	$1.6B	↓ 0.63%

	Q2 FY25	Q/Q Change
Profit	$1.8B	↑ 13.54%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.8B	↑ 0.28%
Investing Cash Flow	$-504.0M	↓ 77.69%
Financing Cash Flow	$-951.0M	↓ 278.42%

	FY20	Y/Y Change
Operating Cash Flow	$2.1B	↑ 18.44%
Investing Cash Flow	$-572.0M	↑ 13.49%
Financing Cash Flow	$123.0M	↓ 112.93%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 4.09%
Investing Cash Flow	$-458.0M	↓ 19.93%
Financing Cash Flow	$-1.9B	↓ 1613.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.9B	↓ 13.6%
Investing Cash Flow	$-883.0M	↑ 92.79%
Financing Cash Flow	$-904.0M	↓ 51.45%

	FY23	Y/Y Change
Operating Cash Flow	$2.4B	↑ 23.06%
Investing Cash Flow	$-777.0M	↓ 12.0%
Financing Cash Flow	$-3.1B	↑ 243.92%

	FY24	Y/Y Change
Operating Cash Flow	$3.0B	↑ 25.5%
Investing Cash Flow	$-315.0M	↓ 59.46%
Financing Cash Flow	$-2.7B	↓ 14.44%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$595.0M	↓ 33.67%
Investing Cash Flow	$-131.0M	↓ 37.62%
Financing Cash Flow	$-524.0M	↑ 31.99%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$502.0M	↓ 15.63%
Investing Cash Flow	$-132.0M	↑ 0.76%
Financing Cash Flow	$-763.0M	↑ 45.61%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$951.0M	↑ 89.44%
Investing Cash Flow	$-178.0M	↑ 34.85%
Financing Cash Flow	$-628.0M	↓ 17.69%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$905.0M	↓ 4.84%
Investing Cash Flow	$126.0M	↓ 170.79%
Financing Cash Flow	$-745.0M	↑ 18.63%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$587.0M	↓ 35.14%
Investing Cash Flow	$-175.0M	↓ 238.89%
Financing Cash Flow	$-677.0M	↓ 9.13%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$486.0M	↓ 17.21%
Investing Cash Flow	$-247.0M	↑ 41.14%
Financing Cash Flow	$-564.0M	↓ 16.69%

Zoetis Technicals Summary

Sell

Neutral

Buy

Zoetis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Zoetis Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zoetis Inc.	2.91%	-7.95%	-14.56%	-1.74%	-2.81%
Haleon Plc Spon Ads	-0.31%	-4.73%	-2.03%	59.31%	30.5%
United Therapeutics Corporation	2.4%	-14.6%	-11.93%	40.37%	71.69%
Neurocrine Biosciences Inc.	0.24%	15.65%	-11.98%	27.26%	17.4%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zoetis Inc.	26.71	26.71	2.54	6.33	0.53	0.15	0.01	11.21
Haleon Plc Spon Ads	21.82	21.82	3.16	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.91	11.91	1.43	26.59	0.19	0.13	NA	158.65
Neurocrine Biosciences Inc.	39.53	39.53	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zoetis Inc.	Buy	$68.8B	-2.81%	26.71	27.83%
Haleon Plc Spon Ads	Buy	$44.2B	30.5%	21.82	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.69%	11.91	40.36%
Neurocrine Biosciences Inc.	Buy	$13.3B	17.4%	39.53	13.88%

Zoetis Dividend announcements

Zoetis Dividends September, 2025
In the quarter ending September,2025. Zoetis has declared dividend of $0.50

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.

Organization	Zoetis
Employees	13800
CEO	Ms. Kristin C. Peck
Industry	Health Technology

Key Management of Zoetis Inc.

Name	Title
Ms. Kristin C. Peck	CEO & Director
Mr. Wetteny N. Joseph CPA	Executive VP & CFO
Ms. Roxanne Lagano	Executive VP, General Counsel & Corporate Secretary
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development
Mr. Jamie Brannan	Executive VP & Chief Commercial Officer
Mr. Keith Sarbaugh	Executive VP & Chief Digital and Technology Officer
Mr. Steven Frank	Vice President of Investor Relations
Ms. Julie A. Fuller	Executive VP, Chief Human Resources Officer & Global Operations
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Chief Sustainability Officer
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply

Important FAQs about investing in ZTS Stock from India :

What is Zoetis share price today?

Zoetis share price today is $155.40 as on August 27, 2025 at 1:29 AM IST. Zoetis share today touched a day high of $156.07 and a low of $155.10.

What is the 52 week high and 52 week low for Zoetis share?

Zoetis share touched a 52 week high of $200.33 and a 52 week low of $139.70. Zoetis stock price today i.e. August 27, 2025 at 1:29 AM IST is trending at $155.40, lower by 22.43% versus the 52 week high.

How to invest in Zoetis Stock (ZTS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zoetis on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zoetis Shares that will get you 0.0097 shares as per Zoetis share price of $155.40 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Zoetis Stock (ZTS) from India?

Indian investors can start investing in Zoetis (ZTS) shares with as little as ₹87.6525 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Zoetis stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Zoetis share’s latest price of $155.40 as on August 27, 2025 at 1:29 AM IST, you will get 0.0644 shares of Zoetis. Learn more about fractional shares .

What are the returns that Zoetis has given to Indian investors in the last 5 years?

Zoetis stock has given -2.81% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?